Trending Topic

20 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Article highlights There is growing clinical importance attributed to the development of metabolic dysfunction-associated steatotic liver disease in people with type 2 diabetes (T2D). Numerous international groups now advocate screening for advanced fibrosis in people with risk factors, such as T2D, using non-invasive biomarkers. This article explores the rationale to screen for advanced fibrosis in people with risk […]

Uberto Pagotto, ESPE 2022: The global health burden and challenges of obesity

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 10th 2022

Paediatric obesity is a major threat to health and longevity. Around 7% of children worldwide have early onset severe obesity before the age of 7. In this touchENDOCRINOLOGY interview, Prof. Uberto Pagotto (IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy) discusses the global health burden of obesity as well as the challenged obesity comes with. 

The abstract entitled: ‘Novel Advances in Obesity‘ was presented at the European Society for Paediatric Endocrinology, 15-17 Sept, 2022.

Questions:

  1. Could you give us a brief overview of the global health burden of obesity? (0:18)
  2. What are the challenges of the treatment of obesity? (2:29)

Disclosures: Uberto Pagotto has received honorarium from Bruno Pharma.

Support: Interview supported by Touch Medical Media. Interview conducted by Shanice Allen.

Recorded as a highlight of ESPE 2022

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup